A stimulus-responsive contrast agent for ultrasound molecular imaging

Area of Science:

• Biomedical Engineering
• Molecular Imaging
• Immunology

Background:

• Complement activation by targeting ligands is a critical challenge for molecular imaging contrast agents.
• Stimulus-responsive systems can control ligand presentation to mitigate adverse immune reactions.

Purpose of the Study:

• To evaluate a stimulus-responsive microbubble construct with a buried-ligand architecture for reduced complement activation and targeted cell adhesion.
• To investigate the molecular mechanism underlying reduced immunogenicity and assess targeting feasibility with a physiological peptide ligand.

Main Methods:

• Utilized ultrasound radiation force to transiently reveal buried ligands on microbubbles.
• Quantified complement component C3/C3b attachment and C3a anaphylotoxin production in vitro and in vivo.
• Assessed adhesion of Arg-Gly-Tyr (RGD)-bearing microbubbles to human umbilical vein endothelial cells (HUVEC) under static and ultrasound-activated conditions.

Main Results:

• The buried-ligand microbubble architecture significantly reduced C3/C3b attachment and C3a production compared to exposed-ligand and no-ligand controls.
• The buried-ligand design prevented microbubble adhesion to HUVEC in static conditions but allowed ultrasound-triggered adhesion.
• Demonstrated feasibility of targeted adhesion using the buried-ligand motif with a physiological ligand-receptor pair.

Conclusions:

• The buried-ligand architecture effectively reduces immunogenicity by minimizing complement activation.
• Ultrasound-triggered revelation of ligands enables controlled and focused cell targeting.
• This approach presents a novel strategy for developing safer and more effective targeted molecular imaging agents.